ARCHIVES

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

This article is from The Cancer Letter archive.

Vol. 31 No. 18 | May 6, 2005

Download PDF Visit The Full Archive

Related Articles

Protocols Approved By NCI During January 2004

February 27, 2004

NCI To Fund 160 P01s FY91, About same As Last Year; Considering New ‘Interactive’ R01

June 21, 1991

In Brief: FASEB Recommends $11.75 Billion NIH Budget; Natcher Wins House Appropriations Chairmanship

December 11, 1992

The Education Of Dan Flood Gets $60 Million Increase For NCI; House Votes HEW Money Bill

July 5, 1974

Petition Filed To Revoke NlH License To Use Radioactive Materials

October 20, 1995

Van Etten To Take Over As Director Of UC Irvine Chao Cancer Center

July 25, 2013